A phase II study for metabolic in vivo response monitoring with sequential 18FDG-PET-CT during treatment with the EGFR-monoclonal-antibody cetuximab in metastatic colorectal cancer: the Heidelberg REMOTUX trial
© Berger et al; licensee BioMed Central Ltd. 2012
Received: 23 January 2012
Accepted: 22 March 2012
Published: 22 March 2012
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|23 Jan 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|2 Feb 2012||Author responded||Author comments - Anne Katrin Berger|
|Resubmission - Version 3|
|2 Feb 2012||Submitted||Manuscript version 3|
|3 Mar 2012||Reviewed||Reviewer Report - Dirk Vordermark|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|22 Mar 2012||Editorially accepted|
|22 Mar 2012||Article published||10.1186/1471-2407-12-108|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.